TREA

87372427 - FLUOTAG

Follow

Information

  • Trademark
  • 87372427
  • Serial Number
    87372427
  • Registration Number
    5441584
  • Filing Date
    March 15, 2017
    8 years ago
  • Registration Date
    April 10, 2018
    7 years ago
  • Transaction Date
    September 30, 2024
    7 months ago
  • Status Date
    September 30, 2024
    7 months ago
  • Published for Opposition Date
    January 23, 2018
    7 years ago
  • Location Date
    September 30, 2024
    7 months ago
  • Status Code
    702
  • Current Location
    Historical data usage
    Employee Name
    LOTT, MAUREEN
  • Attorney Docket Number
    206119606183
    Attorney Name
    Ryan D. Artis
  • Owners
Information
Mark Drawing Code
5
Mark Identification
FLUOTAG
Case File Statements
  • DM0000: The mark consists of the literal element "FluoTag" in stylized letters, with "F" and "T" capitalized.
  • GS0051: Pharmaceutical and veterinary preparations containing antibodies, all for use in treating cancer; Pharmaceutical and veterinary preparations containing antibodies, all for use in treating autoimmune diseases; Pharmaceutical and veterinary preparations containing antibodies, all for use in treating infectious diseases; Pharmaceutical and veterinary preparations containing antibodies, all for use in treating inflammatory diseases; Pharmaceutical and veterinary preparations containing proteins having antibody-like properties, all for use in treating cancer; Pharmaceutical and veterinary preparations containing proteins having antibody-like properties, all for use in treating autoimmune diseases; Pharmaceutical and veterinary preparations containing proteins having antibody-like properties, all for use in treating infectious diseases; Pharmaceutical and veterinary preparations containing proteins having antibody-like properties, all for use in treating inflammatory diseases; Diagnostic preparations for medical or veterinary purposes, namely preparations containing antibodies or proteins having antibody-like properties [ ; Drugs being pharmaceutical preparations containing antibodies, all for use in treating cancer; Drugs being pharmaceutical preparations containing antibodies, all for use in treating autoimmune diseases; Drugs being pharmaceutical preparations containing antibodies, all for use in treating infectious diseases; Drugs being pharmaceutical preparations containing antibodies, all for use in treating inflammatory diseases; Drugs being pharmaceutical preparations containing proteins having antibody-like properties, all for use in treating cancer; Drugs being pharmaceutical preparations containing proteins having antibody-like properties, all for use in treating autoimmune diseases; Drugs being pharmaceutical preparations containing proteins having antibody-like properties, all for use in treating infectious diseases; Drugs being pharmaceutical preparations containing proteins having antibody-like properties, all for use in treating inflammatory diseases; Vaccines containing antibodies; Vaccines containing proteins having antibody-like properties ]
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: Chemical reagents for scientific or industrial purposes and not for medical or veterinary use, namely, chemical reagents containing antibodies or proteins having antibody-like properties; Chemical reagents for scientific or industrial purposes and not for medical or veterinary use, namely, for microscopy, flow cytometry, western blot, imaging, fluorescence based analysis, or tissue analysis; Diagnostic or analytical kits other than for medical or veterinary use containing chemical reagents containing antibodies or proteins having antibody-like properties; Diagnostic or analytical kits other than for medical or veterinary use containing chemical reagents for microscopy, flow cytometry, western blot, imaging, fluorescence based analysis, or tissue analysis
Case File Event Statements
  • 6/9/2017 - 7 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/18/2017 - 8 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 3/21/2017 - 8 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/8/2017 - 7 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/9/2017 - 7 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/9/2017 - 7 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/10/2023 - 2 years ago
    15 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 12/7/2017 - 7 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/7/2017 - 7 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/7/2017 - 7 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/7/2017 - 7 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/3/2018 - 7 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/23/2018 - 7 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/23/2018 - 7 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/10/2018 - 7 years ago
    14 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/26/2024 - 7 months ago
    17 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 9/30/2024 - 7 months ago
    18 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15A
  • 9/30/2024 - 7 months ago
    19 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85
  • 3/22/2024 - a year ago
    16 - TEAS SECTION 8 & 15 RECEIVED Type: E815